The therapeutic program aims to provide optimum pharmacological and nutritional support to control blood sugar level and delay the complications. An 89 year old male patient had a computed tomography scan of the brain. The impression was an acute hemorrhage of the left temporo - parietal lobes which caused the patient to be incoherent and have slurred speech. The bilateral fronto - parietal periventricular and subcortical white matter hypodensities may represent ischemic changes or infarcts due to small vessel arteriosclerosis. The intracranial internal carotid and vertebral arteries were both Atherosclerotic. For the laboratory tests; the RBC dropped at - 3.8 with elevated HDLD - 77.5 mg/dl, FBS - 161.8 mg/dl and HbA1c - 7%. The patient was initially given Citicoline, to accelerate the recovery of consciousness and overcoming motor deficit. He was prescribed to take 250mg Q8 of Acetazolamide, for the management of angle-closure glaucoma.100m IV Q6 of Mannitol was administered to decrease high intraocular pressure through promotion of urinary excretion of toxic materials. The patient was given 500mg BID of Sitagliptin Phosphate, Metformin to improve glycemic control together with Losartan to reduce the risk of stroke and 10mg OD of Rosuvastatin, a lipid lowering treatment.For the regulation of physiologic rhythm of the colon, 30cc of Lactulose was given. The patient's GI tract is functioning normally and so, soft diet was recommended. The diet is complemented with seven scoops of Nutren dissolved in 250ml water The brain hemorrhage can be possibly caused by both uncontrolled diabetes and age-related degeneration. There was a sliding scale administration for Mannitol (75 ml) to manage blood glucose level. After seven days of confinement, the patient was discharged with controlled blood sugar and normal BP. Continuous oral feeding as tolerated with Nutritional Support is recommended to achieve pinnacle of health considering the patient's state and age.